Neuroreader®
General Information
Product name
Neuroreader®
Company
Subspeciality
Neuro
Modality
MR
Disease targeted
Neurodegenerative disorders
Main task
Not specified
Technical Specifications
Population
People with neurogenerative disorders
Patient population age
Not specified
Input
3D, T1, weighted MPRAGE, 1 mm thickness (max 1.2 mm), without contrast (or procontrast)
Input format
DICOM
Output
Segmentation overlay, report with volume metrics
Output format
DICOM, Secondary capture
Integration
Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone webbased
Deployment
Cloud-based, Locally on dedicated hardware
Trigger for analysis
Image upload, On demand, Triggered by a user through e.g. a button click
Processing time
1 - 10 minutes
Regulatory Information
CE Certification
Pathway:
MDD
Class:
Class I
Verified by Health AI Register
FDA Certification
Pathway:
510(k) cleared
Class:
Class II
Verified by Health AI Register
Other certifications
Not specified
Market Presence
On market since
02-2015
AI Platforms
Blackford Analysis
Resellers
Not specified
Countries present
Not specified
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Pay-per-use
Based on
Not specified
Evidence & Research
Source: vendor | First published: Oct 7, 2024 | Last updated: Jul 9, 2025